Poland· PL-100341880

Soolantra

A ivermectin product containing ivermectinum, registered in Poland by Galderma Polska Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC D11AX22

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSoolantraATCD11AX22REGISTER NO.PL-100341880PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Ivermectin is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AX22 (ivermectin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Ivermectin · ATC D11AX22

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ivermectinum
Manufacturer
Galderma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
D11AX22
ATC class
Ivermectin
Defined daily dose
10 mg, T
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991231583
  • gtin
    05909991231576

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for ivermectin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ivermectin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • EchinaceaD03AH02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ivermectin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ivermectin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Ivergelan, Ivermectin Stada
  • Belgium · Cesora, Ivermectin Eg
  • Bulgaria · Ивермектин, Скабал
  • Cyprus · Scaball, Soolantra
  • Czechia · Ivermektin Aristo, Loutol
  • Germany · Driponin, Iveraxiro
  • Denmark · Ivermectin Medical Valley, Ivermectin Newbury
  • Estonia · Ivermectin Orion, Soolantra
  • Spain · Ivercare, Ivergalen
  • Finland · Ivermectin Glenmark, Ivermectin Medical Valley
  • France · Bibovel, Cesora
  • United Kingdom (Northern Ireland) · Ivermectin, Ivermectin Aristo
  • Greece · Scaball, Soolantra
  • Hungary · Soolantra
  • Ireland · Iverscab, Soolantra
  • Iceland · Ivermcetin Stada, Ivermectin Medical Valley
  • Italy · Efacti, Ivercare
  • Lithuania · Ivermectin Orion, Soolantra
  • Luxembourg · Ivermectin Eg, Ivermectin Substipharm
  • Latvia · Ivermectin Orion, Ivermectine Orion
  • Malta · Soolantra
  • Netherlands · Ivergalen, Ivermectin Substipharm
  • Norway · Ivermectin Glenmark, Ivermectin Medical Valley
  • Portugal · Ivergalen, Ivermectina Cantabria
  • Romania · Soolantra
  • Sweden · Cesora, Efrinter
  • Slovakia · Ivermectin Exeltis, Soolantra

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d38a117a-bce4-4df4-acd1-8324b4405243
GET /v1/drugs/d38a117a-bce4-4df4-acd1-8324b4405243?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "10 mg/g",
  "packaging": "05909991231576 ¦ Rp ¦ 109898\n1 tuba 15 g\n05909991231583 ¦ Rp ¦ 109899\n1 tuba 30 g",
  "substance": "Ivermectinum 10 mg/g",
  "common_name": "Ivermectinum",
  "pl_product_id": "100341880",
  "pozwolenie_nr": "22591",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about ivermectin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.